Hegde Priti 4
4 · TCR2 THERAPEUTICS INC. · Filed Aug 26, 2021
Insider Transaction Report
Form 4
Hegde Priti
Director
Transactions
- Award
Stock Option (Right to Buy)
2021-08-25+24,968→ 24,968 totalExercise: $16.02Exp: 2031-08-24→ Common Stock (24,968 underlying)
Footnotes (1)
- [F1]25% of this option shall vest and become exercisable on August 25, 2022, with the remainder vesting in twenty-four (24) equal monthly installments thereafter.